Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4801 AL 4815

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs

Zhang XZ, Qian SS, Zhang YJ, Wang RQ.

Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10.

Rivastigmine for Alzheimer's disease

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3.

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Kishi T, Iwata N.

PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal.pone.0123289. eCollection 2015.

Professional Care Team Burden (PCTB) scale - reliability, validity and factor analysis

Auer S, Graessel E, Viereckl C, Kienberger U, Span E, Luttenberger K.

Health Qual Life Outcomes. 2015 Feb 7;13:17. doi: 10.1186/s12955-014-0199-8.

Latrepirdine for Alzheimer's disease

Chau S, Herrmann N, Ruthirakuhan MT, Chen JJ, Lanctôt KL.

Cochrane Database Syst Rev. 2015 Apr 21;2015(4):CD009524. doi: 10.1002/14651858.CD009524.pub2.

The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial

Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M.

Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z.

A web-based psychoeducational program for informal caregivers of patients with Alzheimer's disease: a pilot randomized controlled trial

Cristancho-Lacroix V, Wrobel J, Cantegreil-Kallen I, Dub T, Rouquette A, Rigaud AS.

J Med Internet Res. 2015 May 12;17(5):e117. doi: 10.2196/jmir.3717.

Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease

Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):192-9. doi: 10.1097/WAD.0000000000000093.

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I.

Int J Neuropsychopharmacol. 2015 May 19;18(10):pyv055. doi: 10.1093/ijnp/pyv055.

Posterior cortical atrophy: an atypical variant of Alzheimer disease

Suárez-González A, Henley SM, Walton J, Crutch SJ.

Psychiatr Clin North Am. 2015 Jun;38(2):211-20. doi: 10.1016/j.psc.2015.01.009. Epub 2015 Mar 12.

Neuropsychiatric management of young-onset dementias

Shinagawa S.

Psychiatr Clin North Am. 2015 Jun;38(2):323-31. doi: 10.1016/j.psc.2015.01.004. Epub 2015 Feb 27.

The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias

Morhardt D, Weintraub S, Khayum B, Robinson J, Medina J, O'Hara M, Mesulam M, Rogalski EJ.

Psychiatr Clin North Am. 2015 Jun;38(2):333-52. doi: 10.1016/j.psc.2015.01.005. Epub 2015 Mar 7.

Effects of noninvasive brain stimulation on cognitive function in healthy aging and Alzheimer's disease: a systematic review and meta-analysis

Hsu WY, Ku Y, Zanto TP, Gazzaley A.

Neurobiol Aging. 2015 Aug;36(8):2348-59. doi: 10.1016/j.neurobiolaging.2015.04.016. Epub 2015 May 1.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

Deardorff WJ, Feen E, Grossberg GT.

Drugs Aging. 2015 Jul;32(7):537-47. doi: 10.1007/s40266-015-0273-x.

Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's disease

Arai H, Umemura K, Ichimiya Y, Iseki E, Eto K, Miyakawa K, Kirino E, Shibata N, Baba H, Tsuchiwata S.

Geriatr Gerontol Int. 2016 May;16(5):644-50. doi: 10.1111/ggi.12516. Epub 2015 Jun 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias